Global Health Limited IPO

Mainboard

Non Banking Financial Company (NBFC)

Listed On: Nov 16, 2022 at ₹ 401.0(NSE)

₹ 14784 /44 Shares

Check Allotment

Price Summary

Last Closing

1,115.00 (231.85%)

52 Week High

1,513.90

52 Week Low

676.00

Last Update

20-Sep-2024 3:30 PM

Global Health IPO Details

03 Nov, 2022

Open Date

07 Nov, 2022

Close Date

11 Nov, 2022

Allotment Date

16 Nov, 2022

Listing Date

Issue Price

₹319-336 per equity share

Face Value

₹2 Per Equity Share

Listing at Group

BSE, NSE

Registrar

KFin Technologies Limited

List Price

401.0(NSE)

Listing Date

2022-11-16

Market Lot

44 Shares (₹14,784/-)
sHNI : 616 Shares (₹2,06,976/-)
bHNI : 2,992 Shares (₹10,05,312/-)

Lead Manager

Kotak Mahindra Capital Company Limited, Credit Suisse Securities (India) Private Limited, Jefferies India Private Limited, JM Financial Consultants Private Limited

Issue Size

Approx 2,205.57 Cr. + Fresh : ₹500 Cr + OFS : 50,761,000 Shares

Retail Portion

35% (Number of Retail Applications : 5,22,150 Approx),
(Number of sHNI Applications : 5,320 Approx),
(Number of bHNI Applications : 10,650 Approx)

Subscription

9.58 times

IPO Docs

DRHP RHP

Global Health IPO Subscription Details

As on	QIB	NII bNII sNII	Retail	Total
Shares Offered / Reserved	5,956,362	4,625,749 3,083,832 1,541,917	10,793,414	21,375,525
Day 1 - 03-11-22 05:00 PM	0.54 x	0.18 0.22 x 0.11 x	0.12 x	0.26 x
Day 2 - 04-11-22 05:00 PM	0.56 x	0.96 1.30 x 0.30 x	0.25 x	0.49 x
Day 3 - 07-11-22 05:00 PM	28.64 x	4.02 5.16 x 1.73 x	0.88 x	9.58 x

Total No. of Applications: 300851 (Approx)

Global Health Valuations

Earnings Per Share (EPS)

₹7.78/-

P/E Ratio

N/A

RoNW

12.14%

Net Asset Value (NAV) - As on 31.03.22

₹63.82

Global Health Company Financials All values are in ₹ Cr.

	30-Jun-22	31-Mar-22	31-Mar-21	31-Mar-20
Assets	3221.94	3145.52	2694.1	2666.29
Revenue	626.54	2205.82	1478.16	1544.27
Profit After Tax	58.71	196.2	28.8	36.33

About The Company

Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.

In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.

As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.

Global Health - Promoter(s)

Pre Issue Share Holding: 35%

Post Issue Share Holding: 33%

Company Promoter(s)

Dr. Naresh Trehan

Global Health IPO - Issue Objectives

Repayment/prepayment of borrowings, in full or part, of the Subsidiaries, GHPPL and MHPL.
General corporate purposes.

Global Health IPO - Anchor Investors

Medanta mobilises Rs 661 crore via anchor book ahead of IPO.
Marquee investors participated in the offer included the Government of Singapore, Marquee investors participated in the offer included the Government of Singapore, Monetary Authority of Singapore, Nomura Trust, Stichting Depositary APG Emerging Markets Equity Pool, Ontario Teachers' Pension Plan Board, Polar Capital Funds Plc, Government Pension Fund Global, Cohesion MK Best Ideas, and Affin Hwang INR Flexi Fund.
Domestic investors such as HDFC Mutual Fund, SBI Mutual Fund, ICICI Prudential, Axis Mutual Fund, Nippon Life, SBI Life Insurance, Edelweiss, Max Life Insurance, Motilal Oswal Mutual Fund, Aditya Birla Sun Life, HDFC Life Insurance, Canara Robeco Mutual Fund, and L&T Mutual Fund also invested in the company via anchor book.

Global Health IPO - FAQs

Ans. Global Health Limited IPO is a Mainboard IPO. The issue is priced at ₹319-336 per equity share. The minimum order quantity is 44 Shares. The IPO opens on Nov 3, 2022, and closes on Nov 7, 2022. KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Global Health Limited IPO opens on Nov 3, 2022 and closes on Nov 7, 2022.

Ans. The size of Global Health Limited IPO is Approx 2,205.57 Cr. + Fresh : ₹500 Cr + OFS : 50,761,000 Shares.

Ans. The IPO price band is set between ₹319-336 per equity share.

Ans. To apply for Global Health Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Global Health Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Global Health Limited IPO is Nov 11, 2022.

Ans. The Global Health Limited IPO will be listed on Nov 16, 2022.

Ans. Follow the steps to check the allotment status for Global Health Limited IPO here.